Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships

Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization. Patient enrollment in SYMON-II clinical trial now approximately 50% completed. Recent private placement transaction completed in